The RITAI Cohort: An Observational Study on Rituximab Off-label Use for Auto-immune Disorders

NCT00960713 · clinicaltrials.gov ↗

COMPLETED

Status

35

Enrollment

OTHER

Sponsor class

Conditions

Pemphigus
Auto-immune Thrombocytopenic Purpura
Hemolytic Auto-immune Anaemia
Cold Agglutinin Disease
Cryoglobulinemia

Interventions

DRUG: Rituximab (MABTHERA® or RITUXAN®).

Sponsor

University Hospital, Toulouse